These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 9890596)
21. Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study. De Hert M; Correll CU; Cohen D Schizophr Res; 2010 Mar; 117(1):68-74. PubMed ID: 20060684 [TBL] [Abstract][Full Text] [Related]
22. Atypical antipsychotic drugs. Two points of clinical interest. Krishnadas R BMJ; 2011 Apr; 342():d2148. PubMed ID: 21467112 [No Abstract] [Full Text] [Related]
23. Causes of death in clozapine-treated patients in a catchment area: a 10-year retrospective case-control study. Rose E; Chen S; Turrion C; Jenkins C; Cardinal RN; Fernandez-Egea E Eur Neuropsychopharmacol; 2020 Jul; 36():160-166. PubMed ID: 32546415 [TBL] [Abstract][Full Text] [Related]
31. Do Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating Overview. Pompili M; Baldessarini RJ; Forte A; Erbuto D; Serafini G; Fiorillo A; Amore M; Girardi P Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27727180 [TBL] [Abstract][Full Text] [Related]
32. The international suicide prevention trial (interSePT): rationale and design of a trial comparing the relative ability of clozapine and olanzapine to reduce suicidal behavior in schizophrenia and schizoaffective patients. Alphs L; Anand R; Islam MZ; Meltzer HY; Kane JM; Krishnan R; Green AI; Potkin S; Chouinard G; Lindenmayer JP; Kerwin R Schizophr Bull; 2004; 30(3):577-86. PubMed ID: 15631247 [TBL] [Abstract][Full Text] [Related]
33. Suicidality in clozapine-treated patients with schizophrenia: role of obsessive-compulsive symptoms. Szmulewicz AG; Smith JM; Valerio MP Psychiatry Res; 2015 Nov; 230(1):50-5. PubMed ID: 26260567 [TBL] [Abstract][Full Text] [Related]
35. Patterns of concomitant psychotropic medication use during a 2-year study comparing clozapine and olanzapine for the prevention of suicidal behavior. Glick ID; Zaninelli R; Hsu C; Young FK; Weiss L; Gunay I; Kumar V J Clin Psychiatry; 2004 May; 65(5):679-85. PubMed ID: 15163255 [TBL] [Abstract][Full Text] [Related]
36. Suicidality in schizophrenia: a review of the evidence for risk factors and treatment options. Meltzer HY Curr Psychiatry Rep; 2002 Aug; 4(4):279-83. PubMed ID: 12126596 [TBL] [Abstract][Full Text] [Related]
37. New vs. old antipsychotics: the Texas experience. Reid WH J Clin Psychiatry; 1999; 60 Suppl 1():23-5; discussion 28-30. PubMed ID: 10037167 [TBL] [Abstract][Full Text] [Related]
38. [Leponex, 10 years after -- a clinical review]. Llorca PM; Pere JJ Encephale; 2004; 30(5):474-91. PubMed ID: 15627052 [TBL] [Abstract][Full Text] [Related]
39. Estimating suicidality as an outcome measure in clinical trials of suicide in schizophrenia. Sakinofsky I; Heila H; Krishnan R Schizophr Bull; 2004; 30(3):587-98. PubMed ID: 15631248 [TBL] [Abstract][Full Text] [Related]
40. Mortality in patients with schizophrenia. Sperling W; Biermann T Lancet; 2009 Nov; 374(9701):1592; author reply 1592-3. PubMed ID: 19897121 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]